ROVIDA, ELISABETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.384
EU - Europa 5.597
AS - Asia 1.128
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 13.143
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.349
PL - Polonia 2.126
RU - Federazione Russa 1.508
IT - Italia 552
SE - Svezia 471
IE - Irlanda 463
CN - Cina 280
SG - Singapore 250
HK - Hong Kong 228
JO - Giordania 132
DE - Germania 110
IN - India 104
FI - Finlandia 94
GB - Regno Unito 91
VN - Vietnam 80
UA - Ucraina 71
CA - Canada 35
CH - Svizzera 32
CI - Costa d'Avorio 29
BE - Belgio 22
TW - Taiwan 14
FR - Francia 11
TR - Turchia 11
AT - Austria 9
NL - Olanda 9
MK - Macedonia 8
ES - Italia 7
JP - Giappone 7
KR - Corea 7
PH - Filippine 5
RO - Romania 4
ID - Indonesia 3
IL - Israele 3
AL - Albania 2
EU - Europa 2
IR - Iran 2
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
EE - Estonia 1
HU - Ungheria 1
LV - Lettonia 1
LY - Libia 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
RS - Serbia 1
Totale 13.143
Salva come PNG Salva come JPEG
Città #
Warsaw 2.126
Santa Clara 1.167
Fairfield 754
Chandler 538
Dublin 458
Ashburn 391
Woodbridge 370
Seattle 328
Cambridge 290
Houston 265
Wilmington 243
Florence 211
Ann Arbor 205
Singapore 203
Jacksonville 149
Hong Kong 135
Princeton 119
Lawrence 110
Beijing 107
Altamura 104
Boston 84
Dong Ket 72
Boardman 65
Mumbai 63
Buffalo 59
San Diego 55
Shanghai 55
Moscow 46
Kent 44
Falls Church 39
Medford 39
Pune 33
Munich 31
Abidjan 29
Bern 28
Brussels 22
Milan 21
Norwalk 21
Ottawa 18
London 17
Phoenix 17
Los Angeles 16
Toronto 15
Yubileyny 15
Redwood City 14
Daan 12
Dearborn 12
Rome 12
Andover 11
Siena 11
Helsinki 9
Guangzhou 8
Prato 8
Vienna 8
Hillsboro 7
Redmond 7
Barcelona 6
Izmir 6
Turin 6
West Jordan 6
Dallas 5
Lappeenranta 5
Laurel 5
Renton 5
Tappahannock 5
Cagliari 4
Cisano Bergamasco 4
Costa Mesa 4
Fuzhou 4
Notre Dame 4
Castelliri 3
Detroit 3
Foggia 3
Hangzhou 3
Islington 3
Kilburn 3
Kyoto 3
Lausanne 3
Lynchburg 3
Malang 3
Menlo Park 3
New York 3
Ohrid 3
Anghiari 2
Augusta 2
Bologna 2
Branford 2
Bremen 2
Chicago 2
Düsseldorf 2
Fremont 2
Garden Grove 2
Hounslow 2
Kaohsiung City 2
Karlskrona 2
Karlsruhe 2
Kochi 2
Nanjing 2
Nuremberg 2
Pavia 2
Totale 9.438
Salva come PNG Salva come JPEG
Nome #
The Colony-Stimulating Factor-1 (CSF-1) Receptor Sustains ERK1/2 Activation and Proliferation in Breast Cancer Cell Lines. 302
One more stem cell niche: how the sensitivity of chronic myeloid leukemia cells to imatinib mesylate is modulated within a “hypoxic” environment 283
The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy. 280
The Leukemic Stem Cell Niche: Adaptation to “Hypoxia” versus Oncogene Addiction 270
Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells. 268
Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine. 267
Hypoxia-resistant profile implies vulnerability of cancer stem cells to physiological agents, which suggests new therapeutic targets. 260
The complex metabolic network gearing the G1/S transition in leukemic stem cells: Hints to a rational use of antineoplastic agents. 258
ERK5 is activated by oncogenic BRAF and promotes melanoma growth 258
Hypoxia selects bortezomib-resistant stem cells of chronic myeloid leukemia. 250
Chronic myeloid leukemia and hepatoblastoma: Two cancer models to link metabolism to stem cells 248
Colony-Stimulating Factor-1 Receptor in the Polarization of Macrophages: A Target for Turning Bad to Good Ones? 247
The expansion of murine bone marrow cells preincubated in hypoxia as an in vitro indicator of their marrow-repopulating ability. 242
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells. 224
Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells 213
The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma. 192
Impact of ERK5 on the Hallmarks of Cancer 181
Low-dose methotrexate enhances cycling of highly anaplastic cancer cells. 178
Different BCR/Abl protein suppression patterns as a converging trait of chronic myeloid leukemia cell adaptation to energy restriction 171
Beyond Kinase Activity: ERK5 Nucleo-Cytoplasmic Shuttling as a Novel Target for Anticancer Therapy 159
The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells 158
Fibronectin induces macrophage migration through a SFK-FAK/CSF-1R pathway 154
1,25-dihydroxyvitamin D3 and erk ½ map kinases in a human chronic myeloid leukemia cell line 147
Glucose availability in hypoxia regulates the selection of chronic myeloid leukemia progenitor subsets with different resistance to imatinib-mesylate 145
HYPOXIA SUPPRESSES BCR/ABL AND SELECTS IMATINIB-INSENSITIVE PROGENITORS WITHIN CLONAL CML POPULATIONS. 139
AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia 139
In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features 133
THE ACTIN CYTOSKELETON AS A NOVEL TARGET OF AMP-ACTIVATED PROTEIN KINASE (AMPK) IN HEPATIC STELLATE CELLS 128
ACTIVATION OF THE MITOGEN-ACTIVATED PROTEIN KINASE ERK5 REGULATES THE DEVELOPMENT AND GROWTH OF HEPATOCELLULAR CARCINOMA 128
Aberrant Glycosphingolipid Pattern in Human Cholangiocarcinoma Stem-Like Subsets 128
Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells 126
Severe hypoxia defines heterogeneity and selects highly immature progenitors within clonal erythroleukemia cells. 125
Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with Colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2 124
Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO positive leukemia cells 122
Ganglioside composition correlates with the malignant phenotype of cholangiocarcinoma cells and modulates cell adhesion 122
CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells 122
ERK5/BMK1 is indispensable for optimal colony-stimulating factor 1 (CSF-1)-induced proliferation in macrophages in a Src-dependent fashion. 118
Interleukin-4 rapidly down-modulates the macrophage colony-stimulating factor receptor in murine macrophages. 117
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma 115
Incubation of murine bone marrow cells in hypoxia ensures the maintenance of marrow-repopulating ability together with the expansion of committed progenitors. 114
The involvement of a Nanog, Klf4 and c-Myc transcriptional circuitry in the intertwining between neoplastic progression and reprogramming 114
Fatty acids regulate the biology of cholangiocarcinoma cells 113
Mitogen-activated protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities? 112
HYPOXIA SUPPRESSES BCR/ABL AND SELECTS IMATINIB-INSENSITIVE PROGENITORS WITHIN CLONAL CML POPULATIONS. 112
The c-Jun-N-terminal-Kinase inhibitor SP600125 enhances the butyrate derivative D1-induced apoptosis via caspase 8 activation in Kasumi 1 t(8;21) acute myeloid leukaemia cells. 110
Interleukin 2 down-modulates the macrophage colony-stimulating factor receptor in murine macrophages. 108
ACTIVATION OF ERK5, A MEMBER OF THE MAPK FAMILY, DIFFERENTIALLY REGULATES PROLIFERATION AND MIGRATION OF HEPATIC STELLATE CELLS 108
Extracellular signal-regulated kinase 5 regulates the malignant phenotype of cholangiocarcinoma cells 108
Low Mr Phosphotyrosine Protein Phosphatase Associates and Dephosphorylates p125 Focal Adhesion Kinase, Interfering with Cell Motility and Spreading 105
Glutamine availability controls bcr/abl protein expression and functional phenotype of chronic myeloid leukemia cells endowed with stem/progenitor cell potential 105
Cytoskeletal rearrangement by the mitogen-activated protein kinase ERK5 interferes with the motile and invasive phenotype of hepatocellular carcinoma cells 105
EPIGENETIC MODIFICATIONS IN A T(8;21) ACUTE MYELOID LEUKAEMIA CELL LINE CAUSED BY ADMINISTRATION OF TWO HDAC INHIBITORS, VPA AND SAHA 104
ERK5 IS OVEREXPRESSED IN EXPERIMENTAL LIVER INJURY AND IN HEPATOCELLULAR CARCINOMA (HCC) AND IS MODULATED BY SOLUBLE FACTORS IN HCC CELLS 104
Enhanced Antitumoral Activity and Photoacoustic Imaging Properties of AuNP-Enriched Endothelial Colony Forming Cells on Melanoma 104
ERK5 differentially regulates PDGF-induced proliferation and migration of hepatic stellate cells. 103
Low M(r) phosphotyrosine protein phosphatase activity on fibroblast growth factor receptor is not associated with enzyme translocation. 102
Possible mechanisms and function of nuclear trafficking of the colony-stimulating factor-1 receptor. 102
c-Rel AND p27Kip ARE DOWNSTREAM TARGETS OF ERK5 IN HEPATOCELLULAR CARCINOMA (HCC) IN VIVO AND IN VITRO 100
Tryptophan availability selectively limits NO-synthase induction in macrophages. 99
Focal adhesion kinase is redistributed to focal complexes and mediates cell spreading in macrophages in response to M-CSF. 99
Opposite effects of different doses of MCSF on ERK phosphorylation and cell proliferation in macrophages. 98
Constitutive activation of the MAPK pathway mediates v-fes-induced mitogenesis in murine macrophages. 94
CYTOSKELETAL REARRANGEMENT BY THE MITOGEN-ACTIVATED PROTEIN KINASE ERK5 INTERFERES WITH THE MOTILE AND INVASIVE PHENOTYPE OF HEPATOCELLULAR CARCINOMA CELLS 93
Inhibition of ERK5 elicits cellular senescence in melanoma via the cyclin-dependent kinase inhibitor p21 93
Salarin C inhibits maintenance of hypoxia-selected Chronic Myeloid Leukemia progenitor cells 92
Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators 92
The low-molecular-weight phosphotyrosine protein phosphatase, when overexpressed, reduces the mitogenic response to macrophage colony-stimulating factor and tyrosine phosphorylation of its receptor. 90
Transmodulation of cell surface regulatory molecules via ectodomain shedding. 89
The Hedgehog-GLI Pathway Regulates MEK5-ERK5 Expression and Activation in Melanoma Cells 88
Playing the Whack-A-Mole Game: ERK5 Activation Emerges Among the Resistance Mechanisms to RAF-MEK1/2-ERK1/2- Targeted Therapy 87
Butyrates as single drug induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blasts. 86
Hepatocyte-specific deletion of HIF2α prevents NASH-related liver carcinogenesis by decreasing cancer cell proliferation 86
CSF1 Determines CSF1R Cytoplasmic Nuclear Shuttling in Breast Cancer Cells 85
Anti-β4 integrin autoantibodies in patients with mucous membrane pemphigoid: a retrospective analysis from a tertiary centre in Italy 84
CHARACTERIZATION OF SIGNALS LINKING THE MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR TO THE FOCAL ADHESION KINASE 83
Targeting chronic myeloid leukemia stem cells with ERK5 pathway inhibitors 82
GLEEVEC-RESISTANT CML STEM AND PROGENITOR CELLS ARE SENSITIVE TO HIF-INHIBITING DRUGS 82
The Culture-Repopulating Ability Assays and Incubation in Low Oxygen: A Simple Way to Test Drugs on Leukaemia Stem or Progenitor Cells 81
GLUCOSE AVAILABILITY IN HYPOXIA REGULATES THE SELECTION OF CML PROGENITOR SUBSETS WITH DIFFERENT RESISTANCE TO IMATINIB-MESYLATE 80
Lipid rafts: integrated platforms for vascular organization offering therapeutic opportunities. 79
L’oncogene fes e la fosfotirosino-fosfatasi citosolica a basso peso molecolare interferiscono con la proliferazione e l’adesione cellulare 78
SPECIFIC DEGRADATION OF THE AML1-ETO/COREPRESSOR COMPLEX BY A NOVEL ORAL HYDROXAMIC ACID DERIVATIVE 78
MAPKS ARE INVOLVED IN THE SURVIVAL AND DIFFERENTIATION OF A T(8;21) ACUTE MYELOID LEUKEMIA CELL LINE AND ARE MODULATED BY THE HDAC INHIBITOR D1 78
The profile on intracellular gangliosides correlates with the malignant phenotype of cholangiocarcinoma cells and modulates cells adhesion 78
INCUBATION OF MURINE ERYTHROLEUKEMIA CELLS IN SEVERE HYPOXIA INDUCES MASSIVE APOPTOSIS PARALLELED BY AKT AND ERK5 CLEAVAGE 78
Lactate maintainsBCR/Abl expression and signalinginChronic Myeloid Leukemia cells under nutrient restriction 78
ENERGY RESTRICTION REGULATES BCR/ABL EXPRESSION IN CHRONIC MYELOID LEUKAEMIA CELLS VIA TRANSCRIPTIONAL/POST-TRANSCRIPTIONAL CONTROL 77
HDAC INHIBITORS IN COMBINATION WITH HYPOMETHYLATING AGENTS INDUCE SPECIFIC CHROMATIN MODIFICATION AND TRANSCRIPTIONAL ACTIVATION IN CBF/AML CELLS 76
HYPOXIA SELECTS DRUG-INSENSITIVE PROGENITORS WITHIN CLONAL LEUKAEMIA CELL POPULATIONS 76
ERK5 inhibition elicits cellular senescence in human melanoma cells 75
BORTEZOMIB SPECIFICALLY TARGETS A SUBSET OF HYPOXIA-SELECTED CML STEM CELLS 73
EPIGENETIC MODIFICATIONS IN A T(8;21) ACUTE MYELOID LEUKEMIA CELL LINE CAUSED BY ADMINISTRATION OF THE HDAC INHIBITOR D1 71
TRAIL IS INVOLVED IN HYPOXIA-INDUCED APOPTOSIS OF ACUTE MYELOID LEUKEMIA T(8;21)-POSITIVE CELLS 70
ERK5-INHIBITION AS A NOVEL APPROACH TO TARGET CML STEM CELLS 70
Bortezomib Specifically Targets a Subset of Hypoxia-Selected CML Stem Cells 69
ROLE OF ERK5 IN THE SURVIVAL OF MYELOID LEUKEMIA CELLS IN HYPOXIA 68
Effects of a human myeloid chronic leukemia cell line (K562) on in vivo angiogenesis 67
Glucose Availability in Hypoxia Regulates the Selection of CML Progenitor Subsets with Different Resistance to Imatinib-Mesylate 67
ACETYLATION INDUCED BY BUTYRATES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA CAN LEAD TO DIFFENTIATION 66
TNF-alpha-converting enzyme cleaves the macrophage colony-stimulating factor receptor in macrophages undergoing activation. 65
Totale 12.674
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.800
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.800
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.621 0 0 0 0 251 242 224 286 205 155 210 48
2020/20211.475 133 155 50 157 69 164 77 109 143 205 83 130
2021/2022940 59 66 44 56 50 54 49 54 68 59 140 241
2022/20232.234 189 366 125 159 155 382 299 142 284 16 67 50
2023/2024886 30 84 122 35 58 114 54 200 25 39 86 39
2024/20253.520 218 581 355 897 1.469 0 0 0 0 0 0 0
Totale 13.358